Skip to main content
. 2021 Jul 2;18(13):7077. doi: 10.3390/ijerph18137077

Table 1.

Characteristics of participants in the STRONG study and LPMT trial.

Characteristic STRONG (N = 45) LPMT Trial (N = 23)
LPMT (n = 13) ^ Waitlist (n = 10) ^
Child characteristics
Gestational age in weeks 27 (26–28) 26 (25–28) 26 (25–28)
Birth weight (grams) 1000 (790–1248) 900 (703–1045) 810 (734–965)
Male sex 22 (49) 6 (46) 3 (30)
Multiple birth 9 (20) 2 (15) & 1 (10)
Apgar 5 min 7.0 (6.0–8.0) 6.0 (4.5–7.5) 7.5 (5.8–9.0)
NICU admission (days) 34.5 (24–45) 39 (24–48) 53 (37–72)
ACS, ≥1 dose 38 (84) 12 (92) 10 (100)
Sectio caesarea 23 (51) 9 (69) 5 (50)
Mechanical ventilation 30 (67) 9 (69) 9 (90)
Inotropic agents 5 (11) 3 (23) 0 (0)
PDA, hemodynamically significant 20 (44) 3 (23) 7 (70) *
NEC 4 (9) 4 (30) 2 (20)
Surgical NEC 2 (4) 2 (15) 1 (10)
Sepsis, culture proven 16 (36) 2 (15) 3 (30)
IVH ≥ grade III 6 (13) 3 (23) 0 (0)
PVL ≥ grade II 1 (2) 1 (8) 0 (0)
Maternal history
First pregnancy 27 (60) 6 (46) 6 (60)
Previously premature childbirth (<32 weeks of gestation) 4 (9) 3 (23) 0 (0)
Social and/or psychological problems 7 (16) 0 (0) 1 (10) #

Data are presented as median (25th–75th percentile) or N (%) where appropriate. STRONG—Stress and Outcomes in NICU Graduates; LPMT trial—Live-Performed Music Therapy trial, 12 infants participated in both studies, of which six in the LPMT group and six in the waitlist group; ACS—antenatal corticosteroids; BPD—bronchopulmonary dysplasia; PDA—persistent ductus arteriosus; NEC—necrotizing enterocolitis; IVH—intraventricular hemorrhage; PVL—periventricular leukomalacia. ^ including one set of twins for which only one set of questionnaires was completed; & one twin sister was deceased before informed consent was obtained; # i.e., financial problems and involvement of child protection services; * p < 0.05 for children in the music therapy versus waitlist group.